Frodl et al. found that MDD patients with less expression of the cortisol markers glucocorticoid-inducible Leucine Zipper (GILZ) or glucocorticoid-inducible kinase-1 (SGK-1) had smaller hippocampal volumes. Here, TSC22D3 is linked to major depressive disorder.